Produktinformation
- 3-(1H-indol-5-yl)-5-[4-[(4-methyl-1-piperazinyl)methyl]phenyl]-1H-Pyrrolo[2,3-b]pyridine
Applications URMC-099 is an orally bioavailable MLK3 inhibitor used in the treatment of Parkinson’s disease and HIV-1 associated neurocognitive disorders.
References Goodfellow, V. et al.: J. Med. Chem., 56, 8032 (2013);